Adjustment of triple shellac coating for precise release of bioactive substances with different physico-chemical properties in the ileocolonic region.
Colon
Enteric coating
Fluidized-bed
Shellac
Subcoat
Targeted release
Journal
International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127
Informations de publication
Date de publication:
10 Jun 2019
10 Jun 2019
Historique:
received:
03
12
2018
revised:
11
04
2019
accepted:
12
04
2019
pubmed:
17
4
2019
medline:
23
11
2019
entrez:
17
4
2019
Statut:
ppublish
Résumé
Formulations for the controlled release of substances in the human terminal ileum and colon are essential to target the gut microbiome and its interactions with the intestinal mucosa. In contrast to pharmaceutical enteric coatings, reliable food-grade alternatives are still scarce. Shellac coatings have been used for various active ingredients, but their stability is affected by the physicochemical properties of the encapsulated substances. It is well known, that shellac release can be modulated by an acidic subcoating. Here, we hypothesized that a triple shellac coating with an adjusted intermediate coating (acidic or alkaline) can be effectively used to counteract the differences in pH value of various encapsulated substances, allowing a precise targeting of the desired release pH value. First, the system was tested with riboflavin 5'-monophosphate sodium salt dihydrate (RMSD) as a characteristic model substance. Secondly, it was transferred to nicotinic acid (NA) and nicotinamide (NAM) as bioactive compounds with different physio-chemical properties: NAM, an alkaline crystalline and highly water-soluble substance, led to a premature release from conventional shellac microcapsules, whereas RMSD and NA with their medium solubility and neutral to acidic pH properties delayed the shellac dissolution. A precise modulation of the release profile of each substance was possible by the addition of different intermediate subcoatings: an acidic layer with citric acid counteracted the premature release of the alkaline and highly soluble NAM. In contrast, an alkaline sodium bicarbonate intermediate subcoating enhanced shellac swelling and delayed the release of NA and RMSD. In conclusion, the novel triple-layer shellac coating provides a much higher adaptability and reliability for nutritional formulations aiming at a targeted release in the ileocolonic region.
Identifiants
pubmed: 30991131
pii: S0378-5173(19)30301-1
doi: 10.1016/j.ijpharm.2019.04.039
pii:
doi:
Substances chimiques
Delayed-Action Preparations
0
Resins, Plant
0
Niacinamide
25X51I8RD4
Niacin
2679MF687A
shellac
46N107B71O
Flavin Mononucleotide
7N464URE7E
Sodium Bicarbonate
8MDF5V39QO
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
472-484Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.